Golimumab Clinical Trials
3 recruitingDrug
Phase 32
Showing 1–3 of 3 trials
Recruiting
Phase 3
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Psoriatic Arthritis
University of Pennsylvania63 enrolled14 locationsNCT05669833
Recruiting
Phase 3
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Rheumatoid Arthritis
University of Nebraska400 enrolled1 locationNCT03414502
Recruiting
CHronic Nonbacterial Osteomyelitis International Registry
Chronic Recurrent Multifocal OsteomyelitisChronic Nonbacterial Osteomyelitis
Seattle Children's Hospital2,000 enrolled1 locationNCT04725422